PREDICTION FOR AND MECHANISM OF RESPONSE TO DENDRITIC CELL (DC)-BASED IMMUNOTHERAPY IN METASTATIC RENAL CELL CARCINOMA (RCC)-GENE EXPRESSION PROFILING OF PERIPHERAL BLOOD LYMPHOCYTES (PBL)

被引：0
|
作者：
Schwaab, Thomas
Hampton, Thomas
Wolf, Benita
Schwarzer, Adrian
Gui, Jiang
Fisher, Jan
Seigne, John
Ernstoff, Marc
机构：
来源：
JOURNAL OF UROLOGY | 2010年 / 183卷 / 04期
关键词：
D O I：
10.1016/j.juro.2010.02.1720
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1796
引用
收藏
页码：E697 / E697
页数：1
相关论文
共 50 条
  • [41] Association of host immune signatures with response to immunotherapy-based regimens in patients with metastatic renal cell carcinoma (mRCC).
    Saad, Eddy
    Labaki, Chris
    Saliby, Renee Maria
    Song, Li
    Bakouny, Ziad
    Pan, Wenting
    Wall, McKenzy
    Lee, Gwo-Shu Mary
    Braun, David A.
    Liu, Xiaole Shirley
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [42] SURGICAL RESECTION OF METASTATIC RENAL-CELL CARCINOMA AND MELANOMA AFTER RESPONSE TO INTERLEUKIN-2-BASED IMMUNOTHERAPY
    SHERRY, RM
    PASS, HI
    ROSENBERG, SA
    YANG, JC
    CANCER, 1992, 69 (07) : 1850 - 1855
  • [43] Peripheral Blood Cell Gene Expression Profiling Predicts Response to Mycophenolate in Systemic Sclerosis Related Interstitial Lung Disease
    Assassi, Shervin
    Zheng, Wenjin
    Volkmann, Elizabeth
    Wang, Xuan
    Wilhalme, Holly
    Lyons, Marka
    Roth, Michael
    Tashkin, Donald
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3853 - 3856
  • [44] Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling
    Furge, K. A.
    Tan, M. H.
    Dykema, K.
    Kort, E.
    Stadler, W.
    Yao, X.
    Zhou, M.
    Teh, B. T.
    ONCOGENE, 2007, 26 (09) : 1346 - 1350
  • [45] Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling
    K A Furge
    M H Tan
    K Dykema
    E Kort
    W Stadler
    X Yao
    M Zhou
    B T Teh
    Oncogene, 2007, 26 : 1346 - 1350
  • [46] Identification and Validation of the Prognostic Panel in Clear Cell Renal Cell Carcinoma Based on Resting Mast Cells for Prediction of Distant Metastasis and Immunotherapy Response
    Su, Yang
    Zhang, Tianxiang
    Lu, Jinsen
    Qian, Lei
    Fei, Yang
    Zhang, Li
    Fan, Song
    Zhou, Jun
    Tang, Jieqiong
    Chen, Haige
    Liang, Chaozhao
    CELLS, 2023, 12 (01)
  • [47] Prediction of response to sunitinib in patients with advanced renal cell carcinoma (RCC) using mass spectrometry-based (phospho) proteomics.
    van der Wijngaart, Hanneke
    Beekhof, Robin
    Knol, Jaco C.
    Henneman, Alex A.
    de Goeij-de Haas, Richard
    Piersma, Sander R.
    Pham, Thang V.
    Jimenez, Connie R.
    Verheul, Henk M. W.
    Labots, Mariette
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Prediction of response to immunotherapy with interferon-α and low-dose interleukin-2 in metastatic renal cell carcinoma based on expression levels of potential molecular markers in radical nepfrectomy specimens
    Muramaki, Mototsugu
    Miyake, Hideaki
    Takenaka, Atsushi
    Kamidono, Sadao
    Fujisawa, Masato
    JOURNAL OF UROLOGY, 2008, 179 (04): : 381 - 381
  • [49] MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients
    Gamez-Pozo, Angelo
    Anton-Aparicio, Luis M.
    Bayona, Cristina
    Borrega, Pablo
    Gallegos Sancho, Maria I.
    Garcia-Dominguez, Rocio
    de Portugal, Teresa
    Ramos-Vazquez, Manuel
    Perez-Carrion, Ramon
    Bolos, Mara V.
    Madero, Rosario
    Sanchez-Navarro, Iker
    Fresno Vara, Juan A.
    Espinosa Arranz, Enrique
    NEOPLASIA, 2012, 14 (12): : 1144 - +
  • [50] Survival with AGS-003, an autologous dendritic cell-based immunotherapy, in combination with sunitinib in unfavorable risk patients with advanced renal cell carcinoma (RCC): Phase 2 study results
    Amin, Asim
    Dudek, Arkadiusz Z.
    Logan, Theodore F.
    Lance, Raymond S.
    Holzbeierlein, Jeffrey M.
    Knox, Jennifer J.
    Master, Viraj A.
    Pal, Sumanta K.
    Miller, Wilson H., Jr.
    Karsh, Lawrence I.
    Tcherepanova, Irina Y.
    DeBenedette, Mark A.
    Williams, W. Lee
    Plessinger, Douglas C.
    Nicolette, Charles A.
    Figlin, Robert A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2015, 3
12345